ArticleMolecular therapy oncolytics2016

LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response.

Tina Chang Albershardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.